810683-27-3

Upstream product

• 108-24-7 acetic anhydride 
• 564476-27-3 2-debenzoyl-2-(2,5-dimethoxybenzoyl)-10-deacetylbaccatin 
• 32981-86-5 10-deacetylbaccatin III 
• 194720-19-9 7,10,13-tris(triethylsilyl)-10-deacetylbaccatin III 
• 204580-30-3 10-O-deacetyl-2-O-debenzoyl-7,10,13-O-tris(triethylsilyl)baccatin III 
• 564476-26-2 C₄₉H₈₂O₁₂Si₃ 

Downstream Products

• 653587-09-8 C₆₂H₈₇NO₁₆SSi₂ 
• 653586-90-4 10-acetoxy-7-(triethylsilyl)-2'-(triisopropylsilyloxy)-3'-dephenyl-3'-(2-furyl)-2-debenzoyl-2-(2,5-dimethoxybenzoyl)-docetaxel 
• 653587-08-7 C₆₀H₈₉NO₁₆SSi₂ 
• 653586-91-5 C₆₀H₈₅NO₁₈Si₂ 
• 653587-07-6 C₅₉H₈₇NO₁₆SSi₂ 
• 653587-10-1 C₆₀H₉₁NO₁₇SSi₂ 
• 653586-89-1 C₆₂H₈₇NO₁₇Si₂ 
• 653586-75-5 C₆₀H₉₃NO₁₆Si₂ 
• 653586-74-4 C₅₉H₉₁NO₁₆Si₂ 
• 653586-88-0 C₆₀H₈₉NO₁₇Si₂ 

Relevant academic research and scientific papers

Synthesis and biological evaluation of novel taxoids designed for targeted delivery to tumors

The use of drug-antibody conjugates affords a method for the targeted delivery of anticancer drugs specifically to cancer cells. Monoclonal antibodies alone usually do not possess high therapeutic efficacy, however, they are capable of targeting tumor mar